Janel Ojeda, PA-C

Janel Ojeda practices at Adventist Health Physicians Network in Lodi, California.

Janel Ojeda's NPI, 1922510171, was assigned on October 27, 2017. Janel Ojeda holds California license 55100.

Janel Ojeda's primary practice is Adventist Health Physicians Network, at 845 S Fairmont Ave, Lodi, CA 95240 in San Joaquin County. The practice phone is (209) 334-8540.

Janel Ojeda's primary practice is Adventist Health Physicians Network in Lodi, California. Janel Ojeda is also affiliated with Adventist Health Lodi Memorial. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Janel Ojeda to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Janel Ojeda practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Janel Ojeda's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Janel Ojeda is licensed in California.

Dmand AI lists acute skin infection, anxiety, asthma, bronchitis, chronic kidney disease, chronic nasal allergies, chronic obstructive pulmonary disease (COPD) and chronic sinusitis among the conditions Janel Ojeda treats.

CMS data shows 437 Medicare services from Janel Ojeda across 8 procedure codes in 2024, for 259 Medicare patients. Medicare paid $28,755 for them. Every service was in an office.

CMS counts 259 Medicare patients who saw Janel Ojeda in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Janel Ojeda's median patient age at 66, with 75% women.

In 2024, Janel Ojeda wrote 2,276 Medicare Part D claims for 666 patients. 86% of them were for generic drugs. CMS names the drug for 1,710 of them, across 53 drugs with 11 or more claims each, at $104,393 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Janel Ojeda for performance year 2024, reported through an alternative payment model (APM). Janel Ojeda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Janel Ojeda as offering telehealth.

CMS Open Payments shows 53 general payments to Janel Ojeda from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $240.